Corbus Pharmaceuticals Holdings (CRBP) Non Operating Income (2013 - 2025)

Corbus Pharmaceuticals Holdings' Non Operating Income history runs 13 years deep, the most recent figure standing at -$50000.0 for Q3 2025.

• In Q3 2025, Non Operating Income fell 102.9% year-over-year to -$50000.0; the TTM figure through Sep 2025 stood at -$122000.0 (down 102.94% YoY), while the FY2024 annual figure was $4.1 million, up 759.28% from the prior year.
• Non Operating Income was -$50000.0 for Q3 2025 at Corbus Pharmaceuticals Holdings, down from $176000.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $12.0 million in Q3 2021 to a low of -$1.4 million in Q4 2024.
• Historically, Non Operating Income has averaged $905505.4 across 5 years, with a median of $77712.0 in 2022.
• The sharpest annual moves came in 2021 and 2022: Non Operating Income jumped 1405.94% in 2021, then tumbled 5995.69% in 2022.
• A 5-year view of Non Operating Income shows it stood at $319372.0 in 2021, then surged by 645.35% to $2.4 million in 2022, then plunged by 106.55% to -$156000.0 in 2023, then plunged by 774.36% to -$1.4 million in 2024, then soared by 96.33% to -$50000.0 in 2025.
• The last three Non Operating Income figures came in at -$50000.0 (Q3 2025), $176000.0 (Q2 2025), and $1.1 million (Q1 2025), per Business Quant data.